Literature DB >> 22588835

High molecular weight constituents of cranberry interfere with influenza virus neuraminidase activity in vitro.

Esther Oiknine-Djian1, Yael Houri-Haddad, Ervin Itshak Weiss, Itzhak Ofek, Evguenia Greenbaum, Kevan Hartshorn, Zichria Zakay-Rones.   

Abstract

Cranberry juice contains high molecular weight non-dialyzable material (NDM) which was found to inhibit hemagglutination induced by the influenza virus (IV) as well as to neutralize the cytotoxicity of IV in cell cultures. Because influenza virus surface glycoproteins hemagglutinin (HA) and neuraminidase (NA) are involved in viral replication and in the infectious process, we sought in the present study to examine the effect of NDM on neuraminidases which are the target of most anti-influenza drugs today. NDM inhibited the NA enzymatic activity of influenza A and B strains as well as that of Streptococcus pneumoniae. This finding is of importance considering the emergence of influenza isolates resistant to antiviral drugs, reaching 90 % in some places. The anti-NA activity of NDM, evaluated by the MUNANA method and expressed as the concentration required for 50 % inhibition (IC₅₀), was most potent against N1 (IC₅₀, 192 µg/mL), less active against BN and N2 (IC₅₀, 509 µg/mL and 1128 µg/mL, respectively), and moderately active against Streptococcus pneumoniae NA (IC₅₀, 594 µg/mL). The in vitro findings of the present study suggest that cranberry constituents may have a therapeutic potential against both A and B influenza virus infections and might also interfere with the development of secondary bacterial complications. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22588835     DOI: 10.1055/s-0031-1298579

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  3 in total

1.  New functionally-enhanced soy proteins as food ingredients with anti-viral activity.

Authors:  Aizhan Sabirzhanovna Turmagambetova; Nadezhda Sergeevna Sokolova; Andrey Pavlinovich Bogoyavlenskiy; Vladimir Eleazarovich Berezin; Mary Ann Lila; Diana M Cheng; Vyacheslav Dushenkov
Journal:  Virusdisease       Date:  2015-08-15

2.  The Cranberry Extract Oximacro® Exerts in vitro Virucidal Activity Against Influenza Virus by Interfering With Hemagglutinin.

Authors:  Anna Luganini; Maria E Terlizzi; Gianluca Catucci; Gianfranco Gilardi; Massimo E Maffei; Giorgio Gribaudo
Journal:  Front Microbiol       Date:  2018-08-07       Impact factor: 5.640

3.  SARS-CoV-2 Survival in Common Non-Alcoholic and Alcoholic Beverages.

Authors:  Mo Jia; Jonathan D Joyce; Andrea S Bertke
Journal:  Foods       Date:  2022-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.